184 related articles for article (PubMed ID: 30465136)
1. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
Xu L; Hu X; Chen W
J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
Liu D; Zhou S; Mao H
J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of circulating coagulation related microRNAs expressions for major adverse cardiac and cerebral event risk in patients undergoing continuous ambulatory peritoneal dialysis: a cohort study.
Wang Y; Liu C; Wei W; Chen W
J Nephrol; 2020 Feb; 33(1):157-165. PubMed ID: 31359371
[TBL] [Abstract][Full Text] [Related]
4. The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study.
Yao C; Zhou L; Huang Q
Medicine (Baltimore); 2021 Mar; 100(10):e24616. PubMed ID: 33725825
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal change in microRNA-130a expression and its correlation with the risk of developing major adverse cardiovascular and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
Wang H; Xu J; Wu X; Zheng S; Han Y; Ding G
J Clin Lab Anal; 2021 Dec; 35(12):e24039. PubMed ID: 34708454
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
Yao C; Ou J; Zhou L; Liu J
Scand J Clin Lab Invest; 2023 Apr; 83(2):119-124. PubMed ID: 36847753
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
[TBL] [Abstract][Full Text] [Related]
8. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in elderly patients on chronic peritoneal dialysis: a retrospective study from a single center in china.
Joshi U; Guo Q; Yi C; Huang R; Li Z; Yu X; Yang X
Perit Dial Int; 2014 May; 34(3):299-307. PubMed ID: 24293663
[TBL] [Abstract][Full Text] [Related]
11. Shortage of Appendicular Skeletal Muscle Is an Independent Risk Factor for Mortality in Peritoneal Dialysis Patients.
Jin S; Lu Q; Su C; Pang D; Wang T
Perit Dial Int; 2017 1-2; 37(1):78-84. PubMed ID: 27282855
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
13. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
Zhang L; Zhao S; Ma J; Gong J; Qiu G; Ren Y; Zen Y; Shi Y
Ren Fail; 2016 Jun; 38(5):815-21. PubMed ID: 26888091
[TBL] [Abstract][Full Text] [Related]
15. High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
Yang X; Tong Y; Yan H; Ni Z; Qian J; Fang W
Am J Nephrol; 2018; 47(5):317-324. PubMed ID: 29779030
[TBL] [Abstract][Full Text] [Related]
16. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis.
Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI
Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216
[TBL] [Abstract][Full Text] [Related]
18. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
19. Five-Year Survival Rate of Patients with End-Stage Renal Disease on Continuous Ambulatory Peritoneal Dialysis (CAPD) at Malang CAPD Center, Indonesia.
Gunawan A; Sakti PT
Acta Med Indones; 2023 Jan; 55(1):4-9. PubMed ID: 36999264
[TBL] [Abstract][Full Text] [Related]
20. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
